Nicotinic Modulation of the Default Network

NCT01223404 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Magnetic Resonance Imaging
Cognition
Nicotine
Mecamylamine

Interventions

DRUG: Placebo
DRUG: Nicotine
DRUG: Mecamylamine

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]